FDA Approved: MODAFINIL — Supplemental Application (CIMA LABS INC.)

View source ↗

Summary

The FDA approved a supplemental application for Modafinil submitted by CIMA Labs Inc., resulting in updated regulatory labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea
• Shift Work Sleep Disorder

Drugs mentioned

• Modafinil (modafinil)

Snippet

SUPPL AP for MODAFINIL (MODAFINIL)